Max Borsche

17PUBLICATIONS
96CO-AUTHORS
PharmacogenomicsNeurology and neuromuscular diseasesAutonomic nervous systemCell and nuclear divisionMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (17)

|May 14, 2025
The role of dopaminergic medication and specific pathway alterations in idiopathic and PRKN/PINK1-mediated Parkinson's disease.

Alexander Balck, Max Borsche, Philip Campbell

|Mar 30, 2024
Genotype-phenotype correlation in PRKN-associated Parkinson's disease.

Poornima Jayadev Menon, Sara Sambin, Baptiste Criniere-Boizet

|Mar 28, 2024
α-Synuclein Pathology in PRKN-Linked Parkinson's Disease: New Insights from a Blood-Based Seed Amplification Assay.

Annika Kluge, Max Borsche, Linn Streubel-Gallasch

|Mar 15, 2024
RFC1 and FGF14 Repeat Expansions in Serbian Patients with Cerebellar Ataxia.

Andona Milovanović, Nataša Dragaševic-Mišković, Mirja Thomsen

|Oct 31, 2023
Characterization of the pathogenic α-Synuclein Variant V15A in Parkinson´s disease.

Sokhna Haissatou Diaw, Max Borsche, Linn Streubel-Gallasch

|Jul 14, 2023
Depressive symptoms in Parkinson's disease are insufficiently but more often treated than in other chronic conditions.

Tatiana Usnich, Björn Hauptmann, Henrike Hanssen

Pageof 3

Frequent Collaborators

7 joint publications

Katja Lohmann

7 joint publications

Christine Klein

5 joint publications

Alexander Balck

4 joint publications

Norbert Brüggemann